Azintuxizumab 是一种靶向 B 细胞成熟抗原 (BCMA) 的 IgG4 双特异性单克隆抗体。Azintuxizumab 具有用于复发/难治性多发性骨髓瘤 (RRMM) 研究的潜力。
| 生物活性 | Azintuxizumab is a monoclonal, B-cell maturation antigen (BCMA)-targeted,IgG4bispecific antibody. Azintuxizumab has the potential for the research of relapsed/refractory multiple myeloma (RRMM)[1]. |
| CAS 号 | |
| 中文名称 | |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
m.cnreagent.com